Search research articles
Contact Us
Filters
Showing results (91-100 of 132) with videos related to
Page
of 14
Sort By:
Breast Cancer : Basic and Clinical Research
|
August 11, 2010
The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines
Kristina Subik, Jin-Feng Lee, Laurie Baxter, et al.
American Journal of Clinical Pathology
|
June 2, 2023
HER2 in uterine serous carcinoma: Current state and clinical perspectives
Janira M Navarro Sanchez, Brian S Finkelman, Bradley M Turner, et al.
Human Pathology
|
May 22, 2012
GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor
Hiroshi Miyamoto, Koji Izumi, Jorge L Yao, et al.
American Journal of Clinical Pathology
|
December 2, 2019
Frequency, Clinicopathologic Characteristics, and Follow-up of HER2-Positive Nonpleomorphic Invasive Lobular Carcinoma of the Breast
Huina Zhang, Ioana Moisini, Rana M Ajabnoor, et al.
The Journal of Biological Chemistry
|
July 31, 2008
Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling
Kedar S Vaidya, Sitaram Harihar, Pushkar A Phadke, et al.
Nutrition and Cancer
|
March 28, 2014
A pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkers
Susan E McCann, Stephen B Edge, David G Hicks, et al.
Journal of Biomedical Optics
|
August 29, 2019
Second-harmonic generation directionality is associated with neoadjuvant chemotherapy response in breast cancer core needle biopsies
Danielle E Desa, Monisha Bhanote, Robert L Hill, et al.
Cancer Investigation
|
August 10, 2010
A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer
Ping Tang, Jianmin Wang, David G Hicks, et al.
Breast (Edinburgh, Scotland)
|
May 24, 2006
A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institution
Joseph P Crowe, Rebecca J Patrick, Lisa A Rybicki, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 18, 2012
Delay to formalin fixation 'cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry
Bryce P Portier, Zhen Wang, Erinn Downs-Kelly, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 132) with videos related to
Sort By:
Page
of 14
Breast Cancer : Basic and Clinical Research
|
August 11, 2010
The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines
Kristina Subik, Jin-Feng Lee, Laurie Baxter, et al.
American Journal of Clinical Pathology
|
June 2, 2023
HER2 in uterine serous carcinoma: Current state and clinical perspectives
Janira M Navarro Sanchez, Brian S Finkelman, Bradley M Turner, et al.
Human Pathology
|
May 22, 2012
GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor
Hiroshi Miyamoto, Koji Izumi, Jorge L Yao, et al.
American Journal of Clinical Pathology
|
December 2, 2019
Frequency, Clinicopathologic Characteristics, and Follow-up of HER2-Positive Nonpleomorphic Invasive Lobular Carcinoma of the Breast
Huina Zhang, Ioana Moisini, Rana M Ajabnoor, et al.
The Journal of Biological Chemistry
|
July 31, 2008
Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling
Kedar S Vaidya, Sitaram Harihar, Pushkar A Phadke, et al.
Nutrition and Cancer
|
March 28, 2014
A pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkers
Susan E McCann, Stephen B Edge, David G Hicks, et al.
Journal of Biomedical Optics
|
August 29, 2019
Second-harmonic generation directionality is associated with neoadjuvant chemotherapy response in breast cancer core needle biopsies
Danielle E Desa, Monisha Bhanote, Robert L Hill, et al.
Cancer Investigation
|
August 10, 2010
A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer
Ping Tang, Jianmin Wang, David G Hicks, et al.
Breast (Edinburgh, Scotland)
|
May 24, 2006
A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institution
Joseph P Crowe, Rebecca J Patrick, Lisa A Rybicki, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 18, 2012
Delay to formalin fixation 'cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry
Bryce P Portier, Zhen Wang, Erinn Downs-Kelly, et al.
Page
of 14